UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
CHEMUNG FINANCIAL CORPORATION
(Name of Issuer)
Common Stock, Par Value $0.01
(Title of Class of Securities)
164024 10 1
(CUSIP Number)
David J. Dalrymple, 274 Coleman Avenue, Elmira, New York 14903;
Telephone: (607) 737-5077 with a copy to J. Philip Hunter, Esq.,
Sayles, Evans, Brayton, Palmer & Tifft, One West Church Street,
Elmira, New York 14901; Telephone: (607) 734-2271
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
October 1, 1998
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this
Schedule 13D, and is filing this schedule because of 240.13d-
1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits.
See 240.13d-7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in
a prior cover page.
The information required on the remainder of this cover page
shall not be deemed "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to
the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
Potential persons who are to respond to the collection of
information contained in this form are not required to respond
unless the form displays a currently valid OMB control number.
CUSIP No. 164024 10 1
1. David J. Dalrymple
2. (b) X
3.
4. OO
5.
6. United States
7. 0
8. 686,054
9. 0
10. 686,054
11. 686,054
12. X
13. 16.67%
14. IN
Instructions for Cover Page
(1) Names and I.R.S. Identification Numbers of Reporting Persons
-Furnish the full legal name of each person for whom the
report is filed - i.e., each person required to sign the
schedule itself - including each member of a group. Do not
include the name of a person required to be identified in
the report but who is not a reporting person. Reporting
persons that are entities are also requested to furnish
their I.R.S. identification numbers, although disclosure of
such numbers is voluntary, not mandatory (see "SPECIAL
INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13D" below).
(2) If any of the shares beneficially owned by a reporting
person are held as a member of a group and the membership is
expressly affirmed, please check row 2(a). If the reporting
person disclaims membership in a group or describes a
relationship with other persons but does not affirm the
existence of a group, please check row 2(b) [unless it is a
joint filing pursuant to Rule 13d-1(k)(1) in which case it
may not be necessary to check row 2(b)].
(3) The 3rd row is for SEC internal use; please leave blank.
CUSIP No. 164024 10 1
1. Robert H. Dalrymple
2. (b) X
3.
4. OO
5.
6. United States
7. 0
8. 686,054
9. 0
10. 686,054
11. 686,054
12. X
13. 16.67%
14. IN
Instructions for Cover Page
(1) Names and I.R.S. Identification Numbers of Reporting Persons
-Furnish the full legal name of each person for whom the
report is filed - i.e., each person required to sign the
schedule itself - including each member of a group. Do not
include the name of a person required to be identified in
the report but who is not a reporting person. Reporting
persons that are entities are also requested to furnish
their I.R.S. identification numbers, although disclosure of
such numbers is voluntary, not mandatory (see "SPECIAL
INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13D" below).
(2) If any of the shares beneficially owned by a reporting
person are held as a member of a group and the membership is
expressly affirmed, please check row 2(a). If the reporting
person disclaims membership in a group or describes a
relationship with other persons but does not affirm the
existence of a group, please check row 2(b) [unless it is a
joint filing pursuant to Rule 13d-1(k)(1) in which case it
may not be necessary to check row 2(b)].
(3) The 3rd row is for SEC internal use; please leave blank.
CUSIP No. 164024 10 1
1. Dalrymple Holding Corporation E.I. No. 16-1137772
2. (b) X
3.
4. OO
5.
6. New York
7. 0
8. 78,316
9. 0
10. 78,316
11. 78,316
12. X
13. 1.90%
14. CO
Instructions for Cover Page
(1) Names and I.R.S. Identification Numbers of Reporting Persons
-Furnish the full legal name of each person for whom the
report is filed - i.e., each person required to sign the
schedule itself - including each member of a group. Do not
include the name of a person required to be identified in
the report but who is not a reporting person. Reporting
persons that are entities are also requested to furnish
their I.R.S. identification numbers, although disclosure of
such numbers is voluntary, not mandatory (see "SPECIAL
INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13D" below).
(2) If any of the shares beneficially owned by a reporting
person are held as a member of a group and the membership is
expressly affirmed, please check row 2(a). If the reporting
person disclaims membership in a group or describes a
relationship with other persons but does not affirm the
existence of a group, please check row 2(b) [unless it is a
joint filing pursuant to Rule 13d-1(k)(1) in which case it
may not be necessary to check row 2(b)].
(3) The 3rd row is for SEC internal use; please leave blank.
CUSIP No. 164024 10 1
1. Dalrymple Family Limited Partnership E.I. No. 16-1478376
2. (b) X
3.
4. OO
5.
6. New York
7. 0
8. 448,510
9. 0
10. 448,510
11. 448,510
12. X
13. 10.90%
14. PN
Instructions for Cover Page
(1) Names and I.R.S. Identification Numbers of Reporting Persons
-Furnish the full legal name of each person for whom the
report is filed - i.e., each person required to sign the
schedule itself - including each member of a group. Do not
include the name of a person required to be identified in
the report but who is not a reporting person. Reporting
persons that are entities are also requested to furnish
their I.R.S. identification numbers, although disclosure of
such numbers is voluntary, not mandatory (see "SPECIAL
INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13D" below).
(2) If any of the shares beneficially owned by a reporting
person are held as a member of a group and the membership is
expressly affirmed, please check row 2(a). If the reporting
person disclaims membership in a group or describes a
relationship with other persons but does not affirm the
existence of a group, please check row 2(b) [unless it is a
joint filing pursuant to Rule 13d-1(k)(1) in which case it
may not be necessary to check row 2(b)].
(3) The 3rd row is for SEC internal use; please leave blank.
This Amendment No. 3 amends the Statement on
Schedule 13D filed with the Securities and Exchange Commission on
March 21, 1994 by Mary E. Dalrymple (such schedule being the
"Schedule 13D"), Amendment No. 1 to the Schedule 13D filed on
January 10, 1995 by Mary E. Dalrymple, David J. Dalrymple, Robert
H. Dalrymple and Dalrymple Holding Corporation pursuant to a
joint filing agreement and Amendment No. 2 to the Schedule 13D
filed on July 13, 1995 by Mary E. Dalrymple, David J. Dalrymple,
Robert H. Dalrymple, Dalrymple Holding Corporation and Dalrymple
Family Limited Partnership pursuant to a joint filing agreement.
(Said Schedule 13D together with Amendments No. 1 and 2 being
filed with respect to the Issuer's formerly-authorized common
stock, par value $5 per share.) This Amendment No. 3 is filed
with respect to the newly-authorized shares of common stock, par
value $0.01 per share (the "Common Stock"), of Chemung Financial
Corporation (the "Issuer"). Since said date, the following
events have occurred:
(1) Mary E. Dalrymple died on March 19, 1997.
(2) Effective May 14, 1998 the aggregate number of
shares the Issuer is authorized to issue is Ten Million
(10,000,000) shares, all of which shall be common shares of
the par value of one cent ($0.01) each.
(3) Effective May 14, 1998 a stock dividend of one
share of common stock of the Issuer, par value $0.01 per
share, was payable on June 1, 1998 to stockholders of record
as of the close of business on May 14, 1998.
The following amendments to Items 1, 2, 3, 5, 6 and 7 of the
Schedule 13D are hereby made. Capitalized terms not otherwise
defined herein have the meanings given them in the Schedule 13D.
Item 1. Security and Issuer.
Item 1 is hereby amended by deleting it in its entirety
and inserting the following in the place thereof:
Common Stock, Par Value $0.01
Chemung Financial Corporation
One Chemung Canal Plaza
Elmira, NY 14902
Item 2. Identity and Background.
Item 2 is hereby amended and supplemented by deleting
Mary E. Dalrymple as an individual reporting person and as a
general partner and limited partner of Dalrymple Family Limited
Partnership. Said Mary E. Dalrymple died on March 19, 1997.
Item 3. Source and Amount of Funds or Other Consideration.
Item 3 is hereby amended by adding the following to the
end thereof:
"All references to ownership by Mary E. Dalrymple who
died on March 19, 1997 shall be deleted.
David J. Dalrymple acquired (i) 1,500 shares by
purchase on the open market on March 29, 1996, (ii) 345 shares on
July 17, 1996 by gift from his late mother, Mary E. Dalrymple,
(ii) 293 shares on January 21, 1997 by gift from his late mother,
Mary E. Dalrymple, and (iii) 43,461 shares on June 1, 1998 as a
result of a 100% stock dividend paid by the Issuer. On February
10, 1997, David J. Dalrymple disposed of 3,000 shares by
transferring same to the Dalrymple Family Limited Partnership.
On June 1, 1998, David J. Dalrymple acquired an additional 1,904
shares as custodian under NYSGMA as a result of a 100% stock
dividend paid by the Issuer.
Robert H. Dalrymple acquired (i) 345 shares on July 17,
1996 by gift from his late mother, Mary E. Dalrymple and
(ii) 32,345 shares on June 1, 1998 as a result of a 100% stock
dividend paid by the Issuer. On February 10, 1997, Robert H.
Dalrymple disposed of 3,000 shares by transferring same to the
Dalrymple Family Limited Partnership. On June 1, 1998, Robert H.
Dalrymple acquired an additional 1,904 shares as custodian under
NYSGMA as a result of a 100% stock dividend paid by the Issuer.
Dalrymple Holding Corporation acquired 39,158 shares on
June 1, 1998 as a result of a 100% stock dividend paid by the
Issuer.
Dalrymple Family Limited Partnership acquired
(i) 103,000 shares on February 10, 1997 as a result of
contributions to said partnership by Mary E. Dalrymple of 97,000
shares and 3,000 shares by each of David J. Dalrymple and Robert
H. Dalrymple, (ii) 18,255 shares on March 10, 1997 as a result of
contributions to said partnership by Mary E. Dalrymple, and
(iii) 224,255 shares on June 1, 1998 as a result of a 100% stock
dividend paid by the Issuer."
Item 5. Interest in Securities of the Issuer.
Item 5 is hereby amended by deleting part (a) in its
entirety and inserting the following in place thereof:
"(a)
David J. Dalrymple
For purposes of Section 13(d) of the Exchange Act,
including the Rules and Regulations thereunder, the aggregate
number of shares of the Common Stock of the Issuer that David J.
Dalrymple may be deemed to beneficially own is 686,054. This
number consists of 86,922 shares held directly in David J.
Dalrymple's name, 64,690 shares held in the name of Robert H.
Dalrymple, 3,808 shares held by David J. Dalrymple as custodian
for his children under the NYSGMA, 3,808 shares held by Robert H.
Dalrymple as custodian for his children under the NYSGMA, 78,316
shares held by Dalrymple Holding Corporation and 448,510 shares
held by Dalrymple Family Limited Partnership. This number does
not include 30,230 shares of the Issuer held by Susquehanna
Supply Company, of which David J. Dalrymple is a 23.1% owner nor
does it include 5,776 shares owned by his spouse, Joanne F.
Dalrymple, of which shares David J. Dalrymple disclaims
beneficial ownership. The aggregate percentage of the issued and
outstanding Common Stock of the Issuer that David J. Dalrymple
may be deemed to beneficially own is 16.67%.
Robert H. Dalrymple
For purposes of Section 13(d) of the Exchange Act,
including the Rules and Regulations thereunder, the aggregate
number of shares of the Common Stock of the Issuer that Robert H.
Dalrymple may be deemed to beneficially own is 686,054. This
number consists of 64,690 shares held directly in Robert H.
Dalrymple's name, 86,922 shares held in the name of David J.
Dalrymple, 3,808 shares held by Robert H. Dalrymple as custodian
for his children under the NYSGMA, 3,808 shares held by David J.
Dalrymple as custodian for his children under the NYSGMA, 78,316
shares held by Dalrymple Holding Corporation and 448,510 shares
held by Dalrymple Family Limited Partnership. This number does
not include 30,230 shares of the Issuer held by Susquehanna
Supply Company, of which Robert H. Dalrymple is a 23.1% owner nor
does it include 2,690 shares owned by his spouse, Elizabeth T.
Dalrymple, of which shares Robert H. Dalrymple disclaims
beneficial ownership. The aggregate percentage of the issued and
outstanding Common Stock of the Issuer that Robert H. Dalrymple
may be deemed to beneficially own is 16.67%.
Dalrymple Holding Corporation
For purposes of Section 13(d) of the Exchange Act,
including the Rules and Regulations thereunder, the aggregate
number of shares of the Common Stock of the Issuer that Dalrymple
Holding Corporation beneficially owns is 78,316. The aggregate
percentage of the issued and outstanding Common Stock of the
Issuer that Dalrymple Holding Corporation beneficially owns is
1.90%.
Dalrymple Family Limited Partnership
For purposes of Section 13(d) of the Exchange Act,
including the Rules and Regulations thereunder, the aggregate
number of shares of the Common Stock of the Issuer that Dalrymple
Family Limited Partnership may be deemed to beneficially own is
448,510 shares. The aggregate percentage of the issued and
outstanding Common Stock of the Issuer that Dalrymple Family
Limited Partnership may be deemed to beneficially own is 10.90%."
Item 5 is further amended by deleting part (b) in its
entirety and inserting the following in place thereof:
"(b)
David J. Dalrymple
David J. Dalrymple may be deemed to share power to vote
or direct the voting and share power to dispose or direct the
disposition of 686,054 shares of the Common Stock of the Issuer.
Robert H. Dalrymple
Robert H. Dalrymple may be deemed to share power to
vote or direct the voting and share power to dispose or direct
the disposition of 686,054 shares of the Common Stock of the
Issuer.
Dalrymple Holding Corporation
Dalrymple Holding Corporation has shared voting and
dispositive power over 78,316 shares of the Common Stock of the
Issuer.
Dalrymple Family Limited Partnership
Acting through its two general partners, Dalrymple
Family Limited Partnership has voting and dispositive power over
448,510 shares of the Common Stock of the Issuer."
Item 5 is further amended by deleting part (c) in its
entirety.
Item 6. Contracts, Arrangements, Understandings or
Relationships
With Respect to Securities of the Issuer.
Item 6 is hereby amended by deleting it in its entirety
and inserting the following in the place thereof:
"David J. Dalrymple and Robert H. Dalrymple are
brothers. As a result of their close family relationship, the
above-named individuals communicate regularly about a variety of
concerns, including financial matters. Although there are no
implicit or explicit arrangements, understandings or contracts
among said persons with respect to the shares of this Issuer
(other than pursuant to the terms of the Dalrymple Family Limited
Partnership Agreement as described at Item 2 hereof), they each
may rely in part on the advice and opinions of the other when
making individual voting or dispositive decisions with respect to
such shares."
Item 7. Material to be Filed as Exhibits.
Item 7 is hereby amended and supplemented by adding the
following as Exhibits to the Schedule 13D:
(1) Joint Filing Agreement, dated October 1, 1998,
among David J. Dalrymple, Robert H. Dalrymple, Dalrymple Holding
Corporation and Dalrymple Family Limited Partnership.
Signature:
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
Dated: October 1, 1998.
Signature:
_______________________________
Name: /s/David J. Dalrymple.
Signature:
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
Dated: October 1, 1998.
Signature:
_______________________________
Name: /s/Robert H. Dalrymple.
Signature:
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
Dated: October 1, 1998.
DALRYMPLE HOLDING CORPORATION
By:
___________________________
Name: /s/David J. Dalrymple
Title: President.
Signature:
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
Dated: October 1, 1998.
DALRYMPLE FAMILY LIMITED
PARTNERSHIP
By:
________________________________
Name: /s/David J. Dalrymple.
Title: General Partner.
By:
________________________________
Name: /s/Robert H. Dalrymple.
Title: General Partner.
EXHIBIT INDEX
Exhibit No. Description Page
No.
1 Joint Filing Agreement between
David J. Dalrymple, Robert H.
Dalrymple, Dalrymple Holding
Corporation and Dalrymple Family
Limited Partnership 16
JOINT FILING AGREEMENT
The undersigned hereby agree that the Statement on
Schedule 13D, as amended by Amendment No. 3, dated October 1,
1998 (the "Schedule 13D") with respect to the Common Stock, par
value $0.01 per share, of Chemung Financial Corporation is, and
any further amendments thereto executed by each of us shall be,
filed on behalf of each of us pursuant to and in accordance with
the provisions of Rule 13d-1(f)(1) under the Securities Exchange
Act of 1934, as amended, and that this agreement shall be
included as an Exhibit to the Schedule 13D and each such
amendment. Each of the undersigned agrees to be responsible for
the timely filing of the Schedule 13D and any amendments thereto,
and for the completeness and accuracy of the information
concerning itself contained therein. This agreement may be
executed in any number of counterparts, all of which taken
together shall constitute one and the same instrument.
IN WITNESS WHEREOF, the undersigned have executed this
Agreement as of the 1st day of October, 1998.
_________________________________________
/s/David J. Dalrymple.
_________________________________________
/s/Robert H. Dalrymple.
DALRYMPLE HOLDING CORPORATION
By
______________________________________
/s/David J. Dalrymple, President
DALRYMPLE FAMILY LIMITED PARTNERSHIP
By ____________________________________
/s/David J. Dalrymple, General
Partner.
